These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22168752)

  • 1. High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10.
    Antonelli A; Ferri C; Ferrari SM; Frascerra S; Ruffilli I; Caponi L; Ulisse S; Miccoli M; Miccoli P; Fallahi P
    J Interferon Cytokine Res; 2012 Feb; 32(2):74-80. PubMed ID: 22168752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis.
    Antonelli A; Ferrari SM; Frascerra S; Di Domenicantonio A; Nicolini A; Ferrari P; Ferrannini E; Fallahi P
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1859-63. PubMed ID: 21470996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10.
    Antonelli A; Ferrari SM; Frascerra S; Galetta F; Franzoni F; Corrado A; Miccoli M; Benvenga S; Paolicchi A; Ferrannini E; Fallahi P
    Cytokine; 2011 Aug; 55(2):288-93. PubMed ID: 21601475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Buonamano A; Ferrannini E; Serio M
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5496-9. PubMed ID: 15531503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Paolicchi A; Ferrannini E; Serio M
    Eur J Endocrinol; 2005 Feb; 152(2):171-7. PubMed ID: 15745922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis.
    Antonelli A; Fallahi P; Ferrari SM; Sebastiani M; Manfredi A; Mazzi V; Fabiani S; Centanni M; Marchi S; Ferri C
    Mod Rheumatol; 2012 Sep; 22(5):659-67. PubMed ID: 22160826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis: Results of the SETI study.
    Pirola I; Rotondi M; Cristiano A; Maffezzoni F; Pasquali D; Marini F; Coperchini F; Paganelli M; Apostoli P; Chiovato L; Ferlin A; Cappelli C
    Endocrinol Diabetes Nutr (Engl Ed); 2020 Jan; 67(1):28-35. PubMed ID: 31196739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy.
    Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
    Thyroid; 2013 Nov; 23(11):1461-9. PubMed ID: 23721189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Romagnani P; Grosso M; Ferrannini E; Serio M
    Eur J Endocrinol; 2006 May; 154(5):651-8. PubMed ID: 16645011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of antibodies to thyrotropin receptors and to thyroid ultrasonographic volume in euthyroid and hypothyroid patients with autoimmune thyroiditis.
    Rieu M; Portos C; Lissak B; Laplanche S; Sambor B; Berrod JL; Fombeur JP
    J Clin Endocrinol Metab; 1996 Feb; 81(2):641-5. PubMed ID: 8636282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2.
    Antonelli A; Fallahi P; Ferrari SM; Corrado A; Sebastiani M; Giuggioli D; Miccoli M; Zignego AL; Sansonno D; Marchi S; Ferri C
    Clin Rheumatol; 2013 Aug; 32(8):1147-54. PubMed ID: 23559389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Frascerra S; Sebastiani M; Franzoni F; Galetta F; Ferrannini E
    Cytokine; 2008 Apr; 42(1):137-43. PubMed ID: 18282714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis.
    Chiovato L; Vitti P; Santini F; Lopez G; Mammoli C; Bassi P; Giusti L; Tonacchera M; Fenzi G; Pinchera A
    J Clin Endocrinol Metab; 1990 Jul; 71(1):40-5. PubMed ID: 2164529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Frascerra S; Pampana A; Panicucci E; Carpi A; Nicolini A; Ferrannini E
    J Interferon Cytokine Res; 2009 Jun; 29(6):345-51. PubMed ID: 19441886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration gradient of CXCL10 and CXCL11 between the cerebrospinal fluid and plasma in children with enteroviral aseptic meningitis.
    Cavčić A; Tešović G; Gorenec L; Grgić I; Benić B; Lepej SŽ
    Eur J Paediatr Neurol; 2011 Nov; 15(6):502-7. PubMed ID: 21703889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.
    Cakir M; Levendoglu F; Kiyici A; Coskun Y
    Autoimmunity; 2011 Sep; 44(6):496-503. PubMed ID: 21457060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
    Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
    Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia.
    Antonelli A; Fallahi P; Ferrari SM; Frascerra S; Mancusi C; Colaci M; Manfredi A; Sansonno D; Zignego AL; Ferri C
    Int J Immunopathol Pharmacol; 2013; 26(1):49-57. PubMed ID: 23527708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low levels of circulating platelet factor 4 (PF4, CXCL4) in subclinically hypothyroid autoimmune thyroiditis.
    Görar S; Ademoğlu E; Çarlıoğlu A; Alioğlu B; Bekdemir H; Sağlam B; Candan Z; Üçler R; Culha C; Aral Y
    J Endocrinol Invest; 2016 Feb; 39(2):185-9. PubMed ID: 26142741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.